A detailed history of Claris Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Claris Advisors, LLC holds 1,503 shares of JNJ stock, worth $219,483. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,503
Previous 1,503 -0.0%
Holding current value
$219,483
Previous $235,000 0.85%
% of portfolio
0.14%
Previous 0.16%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $24,470 - $29,202
-162 Reduced 9.73%
1,503 $232,000
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $15,379 - $17,259
-96 Reduced 5.45%
1,665 $294,000
Q3 2022

Nov 01, 2022

SELL
$161.33 - $179.52 $31,782 - $35,365
-197 Reduced 10.06%
1,761 $288,000
Q2 2022

Jul 28, 2022

SELL
$168.19 - $186.01 $34,310 - $37,946
-204 Reduced 9.44%
1,958 $348,000
Q1 2022

Apr 21, 2022

BUY
$158.14 - $179.59 $10,437 - $11,852
66 Added 3.15%
2,162 $383,000
Q4 2021

Jan 28, 2022

BUY
$155.93 - $173.01 $326,829 - $362,628
2,096 New
2,096 $359,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Claris Advisors, LLC Portfolio

Follow Claris Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claris Advisors, LLC , based on Form 13F filings with the SEC.

News

Stay updated on Claris Advisors, LLC with notifications on news.